Möchten Sie immer auf dem neuesten Stand bleiben?

ווהו, סין, April 30, 2026 (GLOBE NEWSWIRE) -- LEPAS, חברת מותג ה-NEV הפועלת תחת Chery Group, אירחה בין ה-26 ל-28 באפריל 2026 את כנס השותפים הגלובלי הראשון שלה בווהו תחת התמה "מניעים...

BEIJING, China, April 30, 2026 (GLOBE NEWSWIRE) -- Li Auto Inc. (“Li Auto” or the “Company”) (Nasdaq: LI; HKEX: 2015), a leader in China’s new energy vehicle market, today announced that it has...

NEW YORK, April 30, 2026 (GLOBE NEWSWIRE) -- WeRide Inc. (“WeRide” or the “Company”) (Nasdaq: WRD; HKEX: 0800), a global leader in autonomous driving technology, today announced that it will release...

LEPAS accelerates its global rollout through its first Global Partner Conference in Wuhu, showcasing its product lineup, strategic partnerships

LEPAS accelerates its global rollout through its first Global Partner Conference in Wuhu, showcasing its product lineup, strategic partnerships, and ecosys

SHANGHAI, China, April 29, 2026 (GLOBE NEWSWIRE) -- GDS Holdings Limited (“GDS Holdings”, “GDS” or the “Company”) (NASDAQ: GDS; HKEX: 9698), a leading developer and operator of high-performance data...

BEIJING, April 29, 2026 (GLOBE NEWSWIRE) -- KANZHUN LIMITED (“BOSS Zhipin” or the “Company”) (Nasdaq: BZ; HKEX: 2076), a leading online recruitment platform in China, today announced that it filed...

BEIJING, April 29, 2026 (GLOBE NEWSWIRE) -- KANZHUN LIMITED (“BOSS Zhipin” or the “Company”) (Nasdaq: BZ; HKEX: 2076), a leading online recruitment platform in China, today published its 2025...

HONG KONG and SHANGHAI and FLORHAM PARK, N.J., April 29, 2026 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that the New Drug Application...

Orelabrutinib is the first BTKi to demonstrate significant efficacy in a Phase II clinical trial for SLE, which affects around 8 million people worldwide.